Antivertigo
Betahistine dihydrochloride
Each tablet contains:
Betahistine dihydrochloride 16 mg
Excipient q.s.
Each tablet contains:
Betahistine dihydrochloride 24 mg
Excipient q.s.
Bioequivalence: This pharmaceutical product has demonstrated therapeutic equivalence.
Package with 30 tablets
Pathological disorders due to microcirculatory deficit in the labyrinth: vertigo, tinnitus, hearing loss associated with Meniere's syndrome and correlated vertigo conditions.